This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Status of Pending Guidelines Under AHCPR's Revamped Guideline Program
Media Advisory Date: October 3, 1996
As a result of a major restructuring of its clinical practice
guideline program, the Agency for
Health Care Policy and Research (AHCPR) has made the following
decisions about the three
guidelines under development when the change was announced in
- The guideline on screening for Alzheimer's disease, which
was virtually completed at the
time of the restructuring, was completed and released on
September 26, 1996.
- The other two guidelines under development at the time of
restructuring—chronic headache pain and colorectal cancer
screening—were at a less advanced stage, and therefore will
be converted into
AHCPR's first evidence reports.
The evidence reports will include literature reviews, evidence
tables, decision analyses, meta-analyses, and other products.
Under AHCPR's new program, subsequent evidence reports will
be developed by AHCPR-sponsored Evidence-based Practice Centers.
Like the reports for
headache pain and colorectal cancer screening, all
AHCPR-sponsored evidence reports will be
available for use by public- and private-sector organizations
(provider societies, health plans,
purchasing groups, States, and others) to develop and implement
their own clinical practice
guidelines and other quality improvement measures and
The guideline program was revamped in response to the need of
public- and private-sector
organizations for strong scientific foundations for use in
developing their own high-quality,
evidence-based guidelines and other quality improvement tools.
For additional information on AHCPR's restructuring of its
guideline program, see the
statement of May 2,